Ultragenyx Pharmaceutical (RARE) Q4 2017 Earnings

2NovConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
-1.87
-1.79
-1.71
-1.63

Details

Expected EPS
-1.86
Actual EPS
-1.87
Surprise EPS
-0.01
Surprise Percent
+0.54%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.87 per share for Q4 2017.

0 Comments

Share your thoughts